Skip to content

KMTS KMTS Market capitalization

Market capitalization at other companies

Abbott logo
AbbottABT
$178.41B-22.5%
Boston Scientific logo
Boston ScientificBSX
$93.26B-37.5%
Medtronic logo
MedtronicMDT
$103.96B-3.8%
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC
$3.81B+16.0%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$4.1B-34.1%
Haemonetics logo
HaemoneticsHAE
$2.62B-18.0%

Other financials

Income statement

See full
Revenue$24.6M+62.7%
Gross profit$12.9M+97.1%
Operating income-$34.8M-68.8%
Net income-$34.2M-58.8%
EPS (diluted)-$0.61+51.2%

Balance sheet

See full
Cash & equivalents$291.3M+436%
Total debt$43.8M
Total assets$379.3M

Cash flow

See full
Operating cash flow-$18.4M-2.1%
CapEx$9.8M+141%
Free cash flow-$28.2M-27.7%

Valuation

See full
Enterprise value$1.04B
P/S15.4×

Profitability

See full
Gross margin48.8%+15.1pp
Operating margin-171.5%+12.9pp
Net margin-173%+0.8pp
FCF margin-142.9%-25.3pp

Returns & leverage

See full
Current ratio7.3×

Where this comes from

Computed from the period-end share price: $1.44B.

The official record: KMTS’s 10-Q, filed March 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about KMTS's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KMTS's market capitalization?
KMTS (KMTS) reported market capitalization of $1.44B in Q4 2025.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.